+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis



The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis



Journal of Investigative Dermatology. Symposium Proceedings 4(3): 216-219



Many diseases, notably those having a strong autoimmune component, have been shown to have an association with specific human leukocyte antigens (HLA). The molecular basis for this genetic association with disease is the fact that HLA bind and present peptides derived from self and foreign protein antigens to the immune system for recognition and activation of the immune response. Previous studies with heterogeneous groups of alopecia areata (AA) patients have suggested associations with some HLA class I and class II antigens. For this study we selected only patients with long-standing disease and stratified them into two groups by strict definitions of duration and extent of disease: those with patchy AA and those with either alopecia totalis (AT) or alopecia universalis (AU). The patients were tissue typed for HLA class II antigens by biomolecular methods that provided antigen discrimination at an allele level. More than 80% of all of the AA patients typed were positive for the antigen DQB1*03 (DQ3), suggesting that this antigen is a marker for general susceptibility to AA. In addition, two other antigens were found significantly increased in frequency only in the group of AT/AU patients, DRB1*0401 (DR4) and DQB1*0301(DQ7). This strongly suggests that the two clinical types of AA, namely patchy AA versus AT/AU, can be distinguished by a genetically based predisposition to extent of disease.

(PDF emailed within 1 workday: $29.90)

Accession: 047649594

Download citation: RISBibTeXText

PMID: 10674369


Related references

Risk of sun-induced skin cancers in patients with alopecia areata, alopecia totalis and alopecia universalis. Journal of the European Academy of Dermatology and Venereology 32(11): E409-E411, 2018

Long term intra muscular triamcinolone acetonide therapy in alopecia areata alopecia totalis and alopecia universalis. Archiv fuer Dermatologische Forschung 261(1): 73-76, 1978

Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis. Journal of the American Academy of Dermatology 78(6): 1207-1209.E1, 2018

HLA class II alleles in long-standing alopecia totalis/alopecia universalis and long-standing patchy alopecia areata differentiate these two clinical groups. Journal of Investigative Dermatology 104(5 Suppl): 4s-5s, 1995

Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis. Immunology Letters 160(1): 50-57, 2015

Hypnose bij patinten met alopecia areata, areata totalis en alopecia universalis gedeeltelijke of totale kaalhoofdigheid. Directieve Therapie 22(3): 102-111, 2002

Adrenal steroid-genetic activity in subjects with alopecia totalis or subtotalis diffuse alopecia and alopecia areata. Italian General Review of Dermatology 15(1): 13-15, 1978

Alopecia areata versus juvenile alopecia in C3H/HeJ mice: tools to dissect the role of inflammation in focal alopecia. Experimental Dermatology 8(4): 354-355, 1999

Alopecia in an ophiasis pattern: traction alopecia versus alopecia areata. Cutis 89(5): 213-216, 2012

T cell subpopulations and their functions in vitro. A study in patients with alopecia areata and alopecia universalis. International Archives of Allergy and Applied Immunology 66(2): 208-217, 1981

A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. Journal of Immunology 188(1): 477-486, 2012

Clinical and immunologic response to Isoprinosine in alopecia areata and alopecia universalis: association with autoantibodies. Journal of the American Academy of Dermatology 12(1 Pt 1): 78-84, 1985

Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. Journal of the European Academy of Dermatology and Venereology 24(4): 481-485, 2010

Treatment of alopecia areata and alopecia totalis with local corticosteroid preparations. Vestnik Dermatologii i Venerologii 36: 39-43, 1962

The emotional disturbance underlying alopecia areata alopecia totalis and trichotillomania. Child Psychiatry & Human Development 10(2): 114-117, 1979